US EditionA New Method Produces CAR-T Cells to Keep Fighting Disease Longer
33 Articles
33 Articles
New Strategy Emerged to Enhance Sustained Effect of CAR-T Therapy for Cancer and HIV; U.S. Researchers Develop Manufacturing Method to Aid Immune Cell Survival and Proliferation. One of the biggest weaknesses of immunotherapy used to treat cancer and HIV is that its effectiveness weakens over time. Even if it works powerfully at first,
Multi-Cytokine Engineering Strategy May Help CAR T Cell Therapies Last Longer
In a new Science Advances paper, a research team led by scientists at Albert Einstein College of Medicine describe a manufacturing strategy for engineering immune cells that dramatically prolongs their effectiveness after being infused into patients. According to the scientists, their approach, which was tested in mouse models, generated longer-lasting immune cells that provided more sustained control of blood cancers and suppression of HIV infe…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
